Brookhaven National Laboratory

National Virtual Biotechnology Laboratory Symposium, October 28

Harnessing the unique strengths of DOE to tackle the biotechnology challenges of COVID-19

 

WHAT: A virtual symposium to highlight the impact the U.S. Department of Energy’s (DOE) National Virtual Biotechnology Laboratory (NVBL) has had utilizing the unique capabilities of the DOE to tackle the science and technology challenges associated with COVID-19, and to discuss areas in which the NVBL can have impact in the future. The event is aimed at the S&T community, media, and the general public. All attendees must register (including press, link below).

DATE: Wednesday, October 28, 2020

TIME: 11:30 a.m. –  3:30 p.m. U.S. Eastern Time

WHERE: Zoom virtual symposium. Registration link: https://www.zoomgov.com/webinar/register/WN_1nEkc3YYR2ODU-W0ZzODlA

DETAILS: With perspectives from Chris Fall, Director, Office of Science, DOE, and William A. Bookless, Principal Deputy Administrator of the National Nuclear Security Administration, the event will feature presentations from lead investigators from across the DOE complex who will present progress on:

  • Epidemiological modeling
  • Therapeutics
  • Testing
  • Understanding transport of the virus
  • Solving issues around supply chain challenges

In addition, keynote speakers from outside the NVBL will discuss the upcoming science and technology needs in computing, testing and surveillance, and vaccines.

SPEAKERS

  • NVBL Co-Leads Michelle Buchanan, Oak Ridge National Laboratory, and Stephen Streiffer, Argonne National Laboratory, “Overview of Science & Technology Challenges for COVID”
  • Bruce Tromberg, Director, National Institute of Biomedical Imaging & Bioengineering, National Institutes of Health, “Future S&T Needs: Future of Testing & Surveillance”
  • Jim Brase, Deputy Associate Director for Computation, Lawrence Livermore National Laboratory, “Future S&T Needs: AI/ML and Computing”
  • Greg Burel, President, Hamilton Grace, LLC, “Future S&T Needs: Vaccines”
  • Harriet Kung, Deputy Director for Science, DOE Office of Science, “Closing Remarks”

Full agenda available on the NVBL Symposium website.

The U.S. Department of Energy National Virtual Biotechnology Laboratory (NVBL) is a consortium of DOE national laboratories, each with core capabilities relevant to the threats posed by COVID-19. More information can be found at https://science.osti.gov/nvbl. Funding for NVBL is provided by the Coronavirus CARES Act and distributed by the DOE Office of Science. The Office of Science is the single largest supporter of basic research in the physical sciences in the United States and is working to address some of the most pressing challenges of our time. For more information, visit https://www.energy.gov/science/




Filters close

Showing results

110 of 4204
access_time Embargo lifts in 2 days
Embargo will expire: 9-Dec-2020 4:00 PM EST Released to reporters: 3-Dec-2020 4:50 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 9-Dec-2020 4:00 PM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

access_time Embargo lifts in 2 days
Embargo will expire: 9-Dec-2020 4:00 PM EST Released to reporters: 3-Dec-2020 3:50 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 9-Dec-2020 4:00 PM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: 250384_web.jpg
Released: 3-Dec-2020 3:05 PM EST
Study finds COVID-19 hindering US academic productivity of faculty with young children
University of Tennessee Health Science Center

The academic productivity of higher education faculty In the United States in the science, technology, engineering, mathematics, and medicine (STEMM) fields with very young children suffered as a result of the stay-at-home orders during the early months of the coronavirus pandemic, according to a new study by researchers at the University of Tennessee Health Science Center, the University of Florida College of Medicine, and the University of Michigan School of Medicine.

Released: 3-Dec-2020 2:50 PM EST
Kidney disease leading risk factor for COVID-related hospitalization
Geisinger Health System

An analysis of Geisinger's electronic health records has revealed chronic kidney disease to be the leading risk factor for hospitalization from COVID-19.

Newswise: Identity Verification During the Age of COVID-19
Released: 3-Dec-2020 2:25 PM EST
Identity Verification During the Age of COVID-19
Homeland Security's Science And Technology Directorate

S&T's Biometric Technology Rally focused on the ability of acquisition systems and matching algorithms to recognize travelers without asking them to remove their masks, thereby reducing risk for frontline workers.

access_time Embargo lifts in 2 days
Embargo will expire: 10-Dec-2020 11:00 AM EST Released to reporters: 3-Dec-2020 2:20 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 10-Dec-2020 11:00 AM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

access_time Embargo lifts in 2 days
Embargo will expire: 7-Dec-2020 4:45 PM EST Released to reporters: 3-Dec-2020 2:10 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 7-Dec-2020 4:45 PM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 3-Dec-2020 2:00 PM EST
Testosterone May Contribute to More Severe COVID-19 Disease
American Physiological Society (APS)

New research suggests that levels of the sex hormones estrogen and testosterone could contribute to infection risk and severity of COVID-19.

access_time Embargo lifts in 2 days
Embargo will expire: 10-Dec-2020 12:00 PM EST Released to reporters: 3-Dec-2020 1:50 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 10-Dec-2020 12:00 PM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.


Showing results

110 of 4204

close
1.08136